<!DOCTYPE html>
<html>
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<link href="../../../webpages.css" rel="stylesheet"/>
</head>
<body>
<div class="banner">
<div class="banner-content">
<h1>DermpathNet</h1>
</div>
</div>
<nav>
<a href="../../../index.html" target="_blank">
<text type="button">Home</text>
</a>
<a href="../../../browser-page-317.html" target="_blank">
<text type="button">Browse</text>
</a>
<a href="../../../download-page.html" target="_blank">
<text type="button">Downloads</text>
</a>
<a href="../../../contact-us.html" target="_blank">
<text type="button">About</text>
</a>
</nav>
<footer class="site-footer">
<p>@2024 New York University Grossman School of Medicine, Weill Cornell Medicine</p>
<!--<p>Privacy Policy | Terms of Service | Cookie Policy</p>-->
</footer>
<title>Discordant Immune Marker Expression Between Preoperatively Biopsied and Matched Surgically Resected Specimens in Patients With Oral Squamous Cell Carcinoma.-DermPath</title>
<div class="content-container"> <div class="figures-container"> <div class="image-side"> <img alt="Discordant Immune Marker Expression Between Preoperatively Biopsied and Matched Surgically Resected Specimens in Patients With Oral Squamous Cell Carcinoma." class="clickable-image" src="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8112876/bin/cureus-0013-00000014423-i02.jpg"/> </div> <div class="text-side"> <h1>Discordant Immune Marker Expression Between Preoperatively Biopsied and Matched Surgically Resected Specimens in Patients With Oral Squamous Cell Carcinoma.</h1> <p>Biopsy (A-C) and surgically resected specimens (D-F) from a 72-year-old male patient with inferior gingival cancer in the stage of pT4aN0A and D, H&amp;E staining (original magnification X400).B and E, Immunohistochemical analysis of PD-L1 expression (X400) showed approximately &lt;1% tumor staining (nPD-L1 negative) in the biopsy specimen and 20% tumor staining (nPD-L1 positive) in the resection specimen.C and F, Immunohistochemical analysis of PD-1 expression (X400) showed lower number of PD-1-positive TILs (20 cells/HPF) in the biopsy specimen than the number of those (60 cells/HPF) in the resection specimen.H&amp;E, Hematoxylin and eosin; nPD-L1, neoplastic PD-L1; TIL, tumor-infiltrating lymphocytes; HPF, high-power field.</p> <p>PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/33996291/" target="_blank">33996291</a></p><p>Type: Premalignant/Malignant, Category: Keratinocytic</p>
</div> </div></div></body></html>